The invention discloses the use of sapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed.
This application is a divisional of U.S. patent application Ser. No. 10/109,095, filed Mar. 28, 2002, which in turn is a continuation-in-part of International Patent Application No. PCT/GB00/03737, filed Sep. 29, 2000, which is a continuation-in-part of International Patent Application No. PCT/GB99/00951, filed Mar. 26, 1999 and having U.S. National Phase Ser. No. 09/647,110, filed 11 Jan. 2001, now abandoned.
Priority Data
Mar 26, 1998 [GB] 9806513.9 Mar 08, 1999 [GB] 9905275.5 Sep 29, 1999 [GB] 9923076.5
